Immutep Limited (IMMP)
NasdaqGM: IMMP
· 실시간 가격 · USD
0.39
-0.01 (-2.50%)
종가 기준: Aug 18, 2026, 3:59 PM
Immutep Limited (IMMP) Stock Price, Analysis & Data
-2.50% (1D)
IMMP 소개
Immutep Limited, a biotechnology company, engages in developing novel Lymphocyte Activation Gene-3 related immunotherapies for cancer and autoimmune diseases in Australia. Its lead product candidate is the eftilagimod alfa (efti or IMP321), a soluble LAG-3lg fusion based on LAG-3 immune control mechanism for the treatment of different types of cancers. The company's product pipeline also includes TACTI-004, which is in phase III clinical trial fo...
전체 기업 정보애널리스트 전망
애널리스트 1명의 투자의견을 종합하면 IMMP 주식의 평균 등급은 "null"입니다. 12개월 목표주가는 1.5로, 최근 주가 대비 284.62% 상승 여력입니다.
주가 전망
